Find your next paid study

A Two-Part, Randomized, Placebo-Controlled Phase 3 Study of the Efficacy, Safety, and Pharmacokinetics of Mibavademab in Patients With Generalized Lipodystrophy (LAGO)

This study is researching a new drug called mibavademab (called "study drug"). The study involves participants with a condition called Generalized Lipodystroph…